237 related articles for article (PubMed ID: 23437375)
1. Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E.
Cheng PH; Rao XM; McMasters KM; Zhou HS
PLoS One; 2013; 8(2):e57340. PubMed ID: 23437375
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.
Zheng X; Rao XM; Gomez-Gutierrez JG; Hao H; McMasters KM; Zhou HS
J Virol; 2008 Apr; 82(7):3415-27. PubMed ID: 18234796
[TBL] [Abstract][Full Text] [Related]
3. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines.
Cooley A; Zelivianski S; Jeruss JS
Cell Cycle; 2010 Dec; 9(24):4900-7. PubMed ID: 21150326
[TBL] [Abstract][Full Text] [Related]
4. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
[TBL] [Abstract][Full Text] [Related]
5. Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells.
Lunn CL; Chrivia JC; Baldassare JJ
Cell Cycle; 2010 Nov; 9(22):4533-41. PubMed ID: 21088490
[TBL] [Abstract][Full Text] [Related]
6. cAMP-mediated induction of cyclin E sensitizes growth-arrested adipose stem cells to DNA damage-induced apoptosis.
Ugland H; Boquest AC; Naderi S; Collas P; Blomhoff HK
Mol Biol Cell; 2008 Dec; 19(12):5082-92. PubMed ID: 18799628
[TBL] [Abstract][Full Text] [Related]
7. Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression.
Sugatani J; Osabe M; Kurosawa M; Kitamura N; Ikari A; Miwa M
Drug Metab Dispos; 2010 Jan; 38(1):177-86. PubMed ID: 19797611
[TBL] [Abstract][Full Text] [Related]
8. Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.
Akli S; Van Pelt CS; Bui T; Meijer L; Keyomarsi K
Cancer Res; 2011 May; 71(9):3377-86. PubMed ID: 21385896
[TBL] [Abstract][Full Text] [Related]
9. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
Alessi F; Quarta S; Savio M; Riva F; Rossi L; Stivala LA; Scovassi AI; Meijer L; Prosperi E
Exp Cell Res; 1998 Nov; 245(1):8-18. PubMed ID: 9828096
[TBL] [Abstract][Full Text] [Related]
10. Cyclin E-CDK2 protein phosphorylates plant homeodomain finger protein 8 (PHF8) and regulates its function in the cell cycle.
Sun L; Huang Y; Wei Q; Tong X; Cai R; Nalepa G; Ye X
J Biol Chem; 2015 Feb; 290(7):4075-85. PubMed ID: 25548279
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
Musgrove EA; Sarcevic B; Sutherland RL
J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation.
Roy S; He R; Kapoor A; Forman M; Mazzone JR; Posner GH; Arav-Boger R
Antimicrob Agents Chemother; 2015 Jul; 59(7):3870-9. PubMed ID: 25870074
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic Replication of E1b-Deleted Adenoviruses.
Cheng PH; Wechman SL; McMasters KM; Zhou HS
Viruses; 2015 Nov; 7(11):5767-79. PubMed ID: 26561828
[TBL] [Abstract][Full Text] [Related]
14. A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1).
Alevizopoulos K; Catarin B; Vlach J; Amati B
EMBO J; 1998 Oct; 17(20):5987-97. PubMed ID: 9774342
[TBL] [Abstract][Full Text] [Related]
15. LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.
Duong MT; Akli S; Wei C; Wingate HF; Liu W; Lu Y; Yi M; Mills GB; Hunt KK; Keyomarsi K
PLoS Genet; 2012; 8(3):e1002538. PubMed ID: 22479189
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
[TBL] [Abstract][Full Text] [Related]
17. Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma.
Shi XN; Li H; Yao H; Liu X; Li L; Leung KS; Kung HF; Lin MC
Mol Med Rep; 2015 Nov; 12(5):6501-8. PubMed ID: 26398439
[TBL] [Abstract][Full Text] [Related]
18. Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition.
Flores O; Wang Z; Knudsen KE; Burnstein KL
Endocrinology; 2010 Mar; 151(3):896-908. PubMed ID: 20147522
[TBL] [Abstract][Full Text] [Related]
19. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]